Mount Sinai Leads in a New Era of Precision Medicine

Integrating a Patient’s Clinical and Molecular Information for Improved Diagnosis and Treatment

Over 21,000 patients at The Mount Sinai Medical Center are able to receive more precise, personalized care— in real time—based on their own DNA. Each has enrolled in the Mount Sinai Biobank, part of the institution’s Charles Bronfman Institute for Personalized Medicine (IPM), which started accepting patients just over four years ago. Read More [PDF]